Stocks · Health care · Pharmaceutical Preparations

Faeth Therapeutics, Inc.

FTH Clue Score45
United States Fiscal year ends December CIK 0001829802 Results filed 3 Nov 2026

What the insiders did Net buying

By person

20 insiders · 229 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Apeiron Investment Group Ltd. entity
10% owner
$3.54K (2)
$5.44M (2)
−$5.43M
0
$0.00
−100.0%
Cambrian BioPharma Inc entity
10% owner
$4.01M (61)
$787.81K (10)
+$3.22M
130,142
$3.15M
—
James Peyer
10% owner
$4.01M (61)
$787.81K (10)
+$3.22M
5,097,528
$123.46M
+34.9%
Brian C Stephenson
Chief Financial Officer
$1.13M (22)
—
+$1.13M
46,688
$1.13M
—
Robert Hamilton Pierce
Chief R&D Officer
—
$685.96K (4)
−$685.96K
21,000
$508.62K
−78.1%
Millennium Management LLC entity
10% owner
$1.34M (26)
$704.45K (25)
+$637.27K
133,986
$3.25M
+21.7%
Thomas G Ricks
Director
$249.60K (2)
—
+$249.60K
652,470
$15.80M
+116.2%
Anand Kiran Parikh
President and CEO
$55.45K (1)
—
+$55.45K
817,699
$19.80M
—
John Celebi
President and CEO
$425.00 (1)
—
+$425.00
105,862
$2.56M
+936.8%
H&S Investments I LP entity
10% owner
—
—
—
4,425,998
$107.20M
+6,798%
Erin Colgan
Chief Financial Officer
—
—
—
67,462
$1.63M
+596.5%
der Horst Edward van
Chief Scientific Officer
—
—
—
59,794
$1.45M
+80.2%
Stephen M. Hahn
Director
—
—
—
44,763
$1.08M
—
Patrick Stephen Gallagher
Chief Business Officer
—
—
—
43,515
$1.05M
+363.7%
Bob Holmen
Director
—
—
—
25,598
$619.98K
+53.6%
William R Ringo
Director
—
—
—
23,399
$566.72K
—
Kristian Humer
Director
—
—
—
8,932
$216.33K
—
Jessie English
Director
—
—
—
8,932
$216.33K
—
Deneen Vojta
Director
—
—
—
8,932
$216.33K
—
Samuel Broder
Director
—
—
—
8,932
$216.33K
—

No percentages here. This company's share count has moved by a factor of 20.5 over the window, from 1,261,290 to 25,840,425 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.